FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule


Back
Dockets Management
Dockets Entered On August 8, 2006
Table of Contents
Docket # Title
1992S-0251 Electronic Submissions; Establishment of Public Docket
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
2003N-0355 Medical Devices; Exception from General Requirements for Informed Consent
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2006D-0296 International Conference on Harmonisation; Draft Guidance on Q4B Regulatory Acceptance of Analytical Procedures and/or Acceptance Criteria; Annex on Residue on Ignition/Sulphated Ash General Chapter;
2006D-0297 International Conference on Harmonisation; Draft Guidance on Q4B Regulatory Acceptance of Analytical Procedures and/or Acceptance Criteria; Availability
2006P-0101 Petition for Review of Codex Standard for Honey Under 21 CFR 130.6
2006P-0151 Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
2006P-0313 Removal of labeling for MediSense Precision Advanced Diabetes Management System
1992S-0251 Electronic Submissions; Establishment of Public Docket
N 2 FDA Vol #: 1
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 18015 Waiora International Inc Vol #: 166
LET 18016 Waiora International Inc Vol #: 166
LET 18017 WN Pharmaceuticals Ltd Vol #: 166
LET 18018 WN Pharmaceuticals Ltd Vol #: 166
LET 18019 WN Pharmaceuticals Ltd Vol #: 166
LET 18020 WN Pharmaceuticals Ltd Vol #: 166
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 7535 E. Anderson Vol #: 319
EMC 4418 M. Rourke Vol #: 320
EMC 4419 R. Claypool Vol #: 320
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
EMC 254 J. Hagar Vol #: 4
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 1330 A. Rand Vol #: 12
EMC 1331 P. Hafey Vol #: 12
EMC 1332 P. Casasnovas Vol #: 12
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
EMC 9 T. Singeltary Sr. Vol #: 6
2003N-0355 Medical Devices; Exception from General Requirements for Informed Consent
EC 8 Patient Privacy Rights Vol #: 1
EC 9 Health Privacy Project Vol #: 1
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 18000 P. McKern Vol #: 194
C 18001 M. Hahn Vol #: 194
C 18002 V. Gambill Vol #: 194
C 18003 A. Fisch Vol #: 194
C 18004 Illegible Vol #: 194
C 18005 L. Joseph Vol #: 194
C 18006 N. Kaplan Vol #: 194
C 18007 M. Letizan Vol #: 194
C 18008 M. Cole Vol #: 194
EMC 3564 R. Linden Vol #: 176
EMC 3565 G. Orr Vol #: 176
EMC 3566 S. Johnson Vol #: 176
EMC 3567 K. Samborski Vol #: 176
EMC 3568 J. Horn Vol #: 176
EMC 3569 M. Baer Vol #: 176
EMC 3570 C. Hughes Vol #: 176
EMC 3571 L. Feldman Vol #: 176
EMC 3572 O. Diane Vol #: 176
EMC 3573 J. Ferraris Vol #: 176
EMC 3574 C. Hughes Vol #: 176
EMC 3575 M. Hanlon Vol #: 176
EMC 3576 D. Haley Vol #: 176
EMC 3577 M. Stein Vol #: 176
EMC 3578 Start Boyle Vol #: 176
EMC 3579 B. Edmond Vol #: 176
EMC 3580 P. Burdett Vol #: 176
EMC 3581 S. Turner Vol #: 176
EMC 3582 M. Mack Vol #: 176
EMC 3583 R. Jones Vol #: 176
EMC 3584 L. Reynolds Vol #: 176
EMC 3585 J. Wright Vol #: 176
EMC 3586 V. Adams Vol #: 176
EMC 3587 Dr. J. Caldwell Vol #: 176
EMC 3588 D. Wulfe Vol #: 176
EMC 3589 J. Weideman Vol #: 176
EMC 3590 M. Henson Vol #: 176
2006D-0296 International Conference on Harmonisation; Draft Guidance on Q4B Regulatory Acceptance of Analytical Procedures and/or Acceptance Criteria; Annex on Residue on Ignition/Sulphated Ash General Chapter;
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2006D-0297 International Conference on Harmonisation; Draft Guidance on Q4B Regulatory Acceptance of Analytical Procedures and/or Acceptance Criteria; Availability
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2006P-0101 Petition for Review of Codex Standard for Honey Under 21 CFR 130.6
EC 2 National Assn. of State Departments of Agriculture Vol #: 1
2006P-0151 Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
EC 686 Ms. Allison Sherwat Vol #: 3
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
C 2 T. Redding Vol #: 3
2006P-0313 Removal of labeling for MediSense Precision Advanced Diabetes Management System
ACK 1 FDA/DDM to Bayer Corporation Vol #: 1
CP 1 Bayer Corporation Vol #: 1

Page created on August 24, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management